Nov 10, 2020

Coronavirus vaccine 90% successful as clinical trials continue

In the race to develop a viable vaccine for coronavirus, American company Pfizer, has announced their vaccine is currently sitting at a 90% success rate. 

As one of four potential vaccines, the Australian Government has agreed to purchase it if it is successful. This news has come as a welcome relief and caused a surge of optimism as the battle against the spread of the virus continues. 

So far, in early testing, results from the vaccine have shown promising results in 94 infections being treated in the trial. Pfizer, along with their German partner in developing the vaccine, BioNTech, are currently on track to apply to the US Food and Drug Administration (FDA) for emergency use of the vaccine.

Australia’s Federal Health Minister, Greg Hunt, said the Government would monitor any further results as Pfizer’s vaccine trials continue. 

“The data on our vaccine candidates continues to be positive. We will examine the evidence carefully but the latest results are heartening news,” he said.

However, despite this good news, authorities have reinforced the fact that it is unlikely we will see a vaccine fully approved before the end of the year. 

As testing continues on the Pfizer and BioNTech vaccine, it is clear that while these early results are encouraging, there is still a way to go before the vaccine is fully approved for use. As the trials continue, Pfizer has warned that this success rate may change and drop as more COVID-19 infections are added to the calculations. 

While the study and the results are in their earliest stages, this positive result has given hope for the future of vaccines against the virus. 

Dr Anthony Fauci, the United State’s top most expert on infectious diseases called the result “just extraordinary”.

“Not very many people expected it would be as high as that,” he said.

“It’s going to have a major impact on everything we do with respect to COVID.”

If the Pfizer vaccine continues to travel through trials successfully, they estimate they could have 50 million doses, enough to vaccinate 25 million people, available globally by the end of 2020. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Aged care in 2020: ACSA’s Patricia Sparrow reflects on the lessons learned

While this has been a challenging year, we must learn from 2020 and ensure we’re better prepared in the future. This requires more than tinkering around the edges or focussing on single issues. It requires more than platitudes about the efforts and dedication of aged care workers. Read More

Aged Care Minister Asks Providers To Restrict Visits

Residential aged care providers will be encouraged to limit visits from today under national guidelines aimed at the prevention and control of coronavirus. Aged Care Minister Richard Colbeck said the advice from the Communicable Disease Network of Australia issued to aged care facilities around Australia outlines the precautionary measures for residents, staff and their families... Read More

“Each of these ‘little boxes’ in the locked down Melbourne Towers holds a story”, nurse opens up

Each of these ‘little boxes’ in the locked down Melbourne towers holds a story. Someone who matters. We are listening and we care. The past two days I have had the privilege of being one of a team of nurses from Knox Private Hospital providing COVID swabbing for the residents of the towers. This pandemic brings... Read More
Advertisement
Exit mobile version